Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Kambiz Yazdi is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/25/2025 | AVTX | Buy Now | Avalo Therapeutics | $4.97 | 362.73% | Kambiz Yazdi45% | → $23 | Initiates | → Buy | Get Alert |
03/11/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $14.10 | 34.75% | Kambiz Yazdi45% | $16 → $19 | Maintains | Buy | Get Alert |
08/28/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $6.50 | 130.77% | Kambiz Yazdi45% | → $15 | Initiates | → Buy | Get Alert |
08/28/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $14.10 | 6.38% | Kambiz Yazdi45% | → $15 | Initiates | → Buy | Get Alert |
04/12/2024 | PMVP | Buy Now | PMV Pharma | $1.11 | 350.45% | Kambiz Yazdi45% | → $5 | Initiates | → Buy | Get Alert |
03/26/2024 | PRAX | Buy Now | Praxis Precision Medicine | $35.51 | 260.46% | Kambiz Yazdi45% | $75 → $128 | Maintains | Buy | Get Alert |
06/02/2023 | PRAX | Buy Now | Praxis Precision Medicine | $35.51 | -88.74% | Kambiz Yazdi45% | → $60 | Initiates | → Buy | Get Alert |